Since forming in 2010, BCAL Diagnostics has been striving to address the issues surrounding the early detection and more accurate method of screening for breast cancer.
Whilst current imaging technologies are effective in screening for the disease, they have their limitations. Biomarkers for breast cancer would be ideal to overcome these issues, as they eliminate the need for imaging the breast. BCAL Diagnostics recognizes that there is a need for a more accurate screening test for women of all ages, which can detect the cancer at a cellular level and before metastasis.
Published studies shows that there is an association between breast cancer and some specific lipids. This change is detectable directly in breast cancer tissue and cells. The role of these lipids in disease is still being fully understood but their value as metabolites of interest has been established.
- By Greg Collins
- Email: email@example.com